Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Nikolaos, Kentepozidis"'
Autor:
Ourania Nicolatou-Galitis, Amanda Psyrri, Nikolaos Tsoukalas, Evangelos Galitis, Helena Linardou, Dimitra Galiti, Ilias Athansiadis, Despoina Kalapanida, Evangelia Razis, Nikolaos Katirtzoglou, Nikolaos Kentepozidis, Paraskevas Kosmidis, Flora Stavridi, Efthimios Kyrodimos, Danai Daliani, George Tsironis, Giannis Mountzios, Sofia Karageorgopoulou, Panagiotis Gouveris, Konstantinos Syrigos
Publikováno v:
Oral, Vol 3, Iss 1, Pp 123-133 (2023)
The oral problems of 24 cancer patients on immunotherapy between 2017–2022 and referred by their oncologists, were reported. The age range was 49–80 years, and the median was 64 years. Lung cancer was the most common disease. Three patients a had
Externí odkaz:
https://doaj.org/article/504a956c5a954e45a41c0c29d43655f1
Autor:
Stefania Kokkali, Emmanouil Saloustros, Dimitra Stefanou, Paris Makrantonakis, Nikolaos Kentepozidis, Ioannis Boukovinas, Nikolaos Xenidis, Panagiotis Katsaounis, Alexandros Ardavanis, Nikolaos Ziras, Athina Christopoulou, George Rigas, Kostas Kalbakis, Nikolaos Vardakis, Christos Emmanouilides, Ilias Athanasiadis, Athanassios Anagnostopoulos, Dora Hatzidaki, Efthimios Prinarakis, Foteini Simopoulou, Athanasios Kotsakis, Vassilis Georgoulias
Publikováno v:
Current Oncology, Vol 29, Iss 2, Pp 1237-1251 (2022)
Front-line bevacizumab (BEV) in combination with taxanes offers benefit in progression-free survival (PFS) in metastatic breast cancer (mBC). The medical records of mBC patients, treated with front-line BEV-based chemotherapy, were retrospectively re
Externí odkaz:
https://doaj.org/article/c982903354104203bb48bb3d0972f59f
Autor:
Athanasios, Alexopoulos, Charisios, Karanikiotis, Alexandros, Ardavanis, Ioannis, Boukovinas, Parisios, Makrantonakis, Christos, Papadimitriou, Athanasios, Athanasiadis, Anastasios, Boutis, Stylianos, Giassas, Stylianos, Kakolyris, Georgios, Koumakis, Konstantinos, Papazisis, Adamantia, Psyrri, Nikolaos, Ziras, Sofia, Baka, Nikolaos, Kentepozidis, Vasiliki, Michalaki
Publikováno v:
Anticancer Research. 42:1031-1041
This study aimed to provide real-world safety and effectiveness data of everolimus (EVE) plus exemestane (EXE) in estrogen receptor positive/human epidermal growth factor receptor 2 negative (ERThis prospective observational study was conducted by 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f15efa37230a1b0448c0ed9618c5ef88
https://doi.org/10.21873/anticanres.15564
https://doi.org/10.21873/anticanres.15564
Autor:
Stefania Kokkali, Emmanouil Saloustros, Dimitra Stefanou, Paris Makrantonakis, Nikolaos Kentepozidis, Ioannis Boukovinas, Nikolaos Xenidis, Panagiotis Katsaounis, Alexandros Ardavanis, Nikolaos Ziras, Athina Christopoulou, George Rigas, Kostas Kalbakis, Nikolaos Vardakis, Christos Emmanouilides, Ilias Athanasiadis, Athanassios Anagnostopoulos, Dora Hatzidaki, Efthimios Prinarakis, Foteini Simopoulou, Athanasios Kotsakis, Vassilis Georgoulias
Publikováno v:
Current Oncology; Volume 29; Issue 2; Pages: 1237-1251
Front-line bevacizumab (BEV) in combination with taxanes offers benefit in progression-free survival (PFS) in metastatic breast cancer (mBC). The medical records of mBC patients, treated with front-line BEV-based chemotherapy, were retrospectively re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d912d22acc3a1f5d3ceb8791b527d9c
https://pubmed.ncbi.nlm.nih.gov/35200604
https://pubmed.ncbi.nlm.nih.gov/35200604
Autor:
Giannis Mountzios, Athanasios Laloysis, Sofia Lampaki, Dimitrios Daoussis, Henry Vo, George Papaxoinis, I. Binas, A. Kotsakis, Anastasios Boutis, Amanda Psyrri, Vassilis Georgoulias, Georgia Angeliki Koliou, Helena Linardou, Anastasios Vagionas, Sofia Levva, Eleni Res, Iliada Bompolaki, Elena Fountzilas, Dimitrios Bafaloukos, Helen Gogas, Emmanouil Saloustros, Athina Christopoulou, Adamantia Nikolaidi, George Fountzilas, Elias Kotteas, Anna Andreadou, Anna Koumarianou, Miltiadis Chrysanthidis, Konstantinos N. Syrigos, Marinos Tsiatas, Dionisios Spyratos, Nikolaos Kentepozidis
Publikováno v:
Cancer Immunology, Immunotherapy
Background Data on the safety and efficacy of immune checkpoint inhibitors (ICI) in patients with concurrent autoimmune diseases (AID) are limited. Methods We performed a retrospective multicenter review of medical records of patients with cancer and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03e316ea46ea39066f9623e7567ba0d1
https://doi.org/10.1007/s00262-021-02985-6
https://doi.org/10.1007/s00262-021-02985-6
Autor:
Pavlos Papakostas, Konstantinos Ferentinos, Grigorios Rallis, Ioannis Varthalitis, Christos Dervenis, George Fountzilas, Georgios Rigakos, Alexia Eliades, Charalambos Loizides, Nikolaos Kentepozidis, Elena Kypri, Elena Fountzilas, Gerasimos Aravantinos, Paris Kosmidis, Epaminontas Samantas, Athina Christopoulou, Georgios Oikonomopoulos, Kyriakos Tsangaras, Adamantia Nikolaidi, Dimitrios Pectasides, Achilleas Achilleos, George Koumbaris, Anna Koumarianou, George Zarkavelis, Philippos C. Patsalis, Marios Ioannides, Maria Theochari, Zacharenia Saridaki, Joseph Sgouros, Amanda Psyrri, George Papaxoinis, Dimitrios Bafaloukos, Christos Papadimitriou, Florentia Fostira, Georgia-Angeliki Koliou
Publikováno v:
Cancers, Vol 13, Iss 198, p 198 (2021)
Cancers
Volume 13
Issue 2
Cancers
Volume 13
Issue 2
Simple Summary Data on the prognostic and predictive value of germline cancer predisposing pathogenic/likely pathogenic variants (P/LPVs) in patients with pancreatic ductal adenocarcinoma is limited. This research was a study of germline testing of 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baeacc4bc2fa5f8000b02450160ad436
https://www.mdpi.com/2072-6694/13/2/198
https://www.mdpi.com/2072-6694/13/2/198
Autor:
Panagiota Economopoulou, Giannis Mountzios, Ioannis Kotsantis, Marios Bakogeorgos, Vassilios Ramfidis, Ioannis Kapiris, Efstratios Patsouris, Nikolaos Kentepozidis
Publikováno v:
Case Reports in Medicine, Vol 2013 (2013)
Herein, we report an unusual case of a 78-year-old woman with synchronous presentation of sigmoid cancer and a nonfunctioning primary adrenal cortex carcinoma, who developed superior vena cava syndrome due to metastatic lymphadenopathy from the latte
Externí odkaz:
https://doaj.org/article/366621e279db46b8928ce71aab938612
Autor:
Athanasios D. Giannoukas, Ioannis Boukovinas, Christos Papadimitriou, Nicos Labropoulos, Nikolaos Kentepozidis, Eleni Arnaoutoglou, Miltiadis Matsagkas, Stavros K. Kakkos, Haralabos P. Kalofonos, Ioannis A. Tsolakis
Publikováno v:
International Angiology. 39
Background Our knowledge on the burden of symptomatic and asymptomatic venous thromboembolism (VTE) in patients with cancer undergoing chemotherapy is limited. The aim of our study was to prospectively investigate the frequency of symptomatic VTE and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d39972f6bfe82f219cc0979d1babe7f
https://doi.org/10.23736/s0392-9590.20.04272-8
https://doi.org/10.23736/s0392-9590.20.04272-8
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 10406, p 10406 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 10406, p 10406 (2021)
Multiple myeloma (MM) is a malignancy of terminally differentiated plasma cells, and accounts for 10% of all hematologic malignancies and 1% of all cancers. MM is characterized by genomic instability which results from DNA damage with certain genomic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc6d9cdc8b13dc94ce11b2b397f92a08
https://doi.org/10.3390/ijms221910406
https://doi.org/10.3390/ijms221910406